UCARsgen Biotech Limited
UCARsgen Biotech Limited
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I/II Trial of CT1190B in Patients With Relapsed/Refractory Large B-Cell Lymphoma | Large B-Cell Lymphoma (LBCL) | Recruiting | Phase 1 / Phase 2 | 2026-10-01 | NCT07823829 | |
| A Clinical Study of CT0596 CAR-T in Relapsed/Refractory Multiple Myeloma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 1 / Phase 2 | 2026-09-17 | NCT07760454 |